Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Twenty percent of people with epilepsy develop drug Rrsistant seizures

Yale University : 06 February, 2003  (New Product)
Twenty percent of people with epilepsy will eventually develop seizures that are resistant to medication, even if they have experienced long periods with no seizures at all, according to a study led by a Yale researcher.
The large multi-center trial included 333 persons who sought surgery at six medical centers in the Northeast and one in the Midwest because their seizures could no longer be controlled by medication, said Susan Spencer, M.D., a professor of neurology at Yale School of Medicine.

'We did very detailed histories to see when their seizures began and when they failed their first and second drug treatment and how long it took to get to that point,' said Spencer, senior author of the study published in the current issue of the journal, Neurology.

More than 25 percent of the patients had had a long period of complete seizure control. Some even went off their medication. Nearly 10 percent of these patients had no seizures for an interval of five years. A significant number, Spencer said, also had more than one seizure-free interval.

'We don't know what predicts this group,' she said, 'although the people who were younger at the time of their first seizure were the most likely to become controlled for some interval of time.'

Spencer said one purpose of the research is to try to predict from the onset of the first seizure which patients will eventually become resistant to medication and which ones will be able to control their seizures with medication.

'There has been increasing inclination when surgery might be appropriate treatment to do it earlier and earlier,' she said. The definition adopted by many medical centers on when surgery for epilepsy is appropriate is when a person has become resistant to a second medication for their seizures.

The researchers said in the study that much remains unknown about the natural history of intractable epilepsy, including how long it typically takes before intractability becomes evident. The new data, they said, could guide the design of future studies, resolve certain discrepancies in the literature, and provide more accurate information about long-term prognosis.

'The possibility that an early benign course does not necessarily ensure a good long-term outcome is sobering news,' Spencer said. 'However, if it is true, then we may also be able to learn to identify early those patients who will later develop intractable temporal lobe epilepsy regardless of a relatively benign initial course. This raises the possibility of identifying the mechanisms involved in this progression and could eventually open the door to therapeutic approaches that might prevent some forms of epilepsy from becoming intractable.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 NewMaterials.com
Netgains Logo